MedTrace Logo

Safety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell Carcinoma

NCT06756841 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-01-03

No results posted yet for this study

Summary

The goal of this clinical trial is to verify the safety and clinical benefit of pulsed electric field (PEF) treatment of advanced or unresectable esophageal squamous cell carcinoma patients.

The main questions it aims to answer are:

* Safety and feasibility of PEF treatment of patients with advanced or unresectable esophageal squamous cell carcinoma.
* Locoregional control of ablated lesions and quality of life assessment.
* Local and peripheral immunoregulation effect.

Conditions

  • Esophageal Cancer

Interventions

DEVICE

PEF treatment

PEF energy delivery via endoscope

Sponsors & Collaborators

  • Energenx Medical LTD.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-25
Primary Completion
2025-07-31
Completion
2026-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06756841 on ClinicalTrials.gov